NF-kappaB p65 Antibody

Catalog Number: ASB-OAAF08207
Article Name: NF-kappaB p65 Antibody
Biozol Catalog Number: ASB-OAAF08207
Supplier Catalog Number: OAAF08207
Alternative Catalog Number: ASB-OAAF08207-100UG
Manufacturer: Aviva
Host: Rabbit
Category: Proteine/Peptide
Application: ELISA, ICC, IF, IHC, IHC-P, WB
Species Reactivity: Human, Monkey, Mouse
Immunogen: The antiserum was produced against synthesized peptide derived from human NF-kappaB p65.
Alternative Names: CMCU,NF-kappa-B p65delta3,NF-kappa-B transcription factor p65,NFKB3,nuclear factor NF-kappa-B p65 subunit,nuclear factor of kappa light polypeptide gene enhancer in B-cells 3,p65,transcription factor p65,v-rel avian reticuloendotheliosis viral oncogene homolog A.
NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and p65-c-Rel complexes are transcriptional activators. The NF-kappa-B p65-p65 complex appears to be involved in invasin-mediated activation of IL-8 expression. The inhibitory effect of I-kappa-B upon NF-kappa-B the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1. Essential for cytokine gene expression in T-cells (PubMed:15790681).
Clonality: Polyclonal
Concentration: 1 mg/ml
Molecular Weight: 60 kDa
NCBI: 5970
UniProt: Q04206
Form: Liquid. PBS (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol
Western blot analysis of lysates from COS7 cells, treated with sorbitol 0.4M